Yiviva

Yiviva: Innovating Biotechnology for Aging-Associated Diseases

Yiviva is a biotechnology company, co-founded by Yale University, focused on developing therapeutics to combat aging-associated diseases, particularly in the fields of oncology and gastroenterology. Established in 2014 and headquartered in the United States, Yiviva embodies the ethos of "Modern Science + Ancient Wisdom = Innovation + Impact."

The company's most recent milestone was its Series A investment on the 29th of October, 2018. Yiviva continues to attract attention in the biotechnology and healthcare sectors, positioning itself as a promising opportunity for venture capital investment.

Yiviva's unique approach, combining cutting-edge science with traditional knowledge, sets it apart within the biotechnology landscape. As the company forges ahead in its mission to tackle aging-related illnesses, it presents an intriguing prospect for investors seeking innovative and impactful ventures in the biotech sphere.